logo
Search…
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Search...
search
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Home > Stocks > HK Stock

On July 15th, TIANGE (01980) spent HK$21,800 to repurchase 37,000 shares.

date
18:16 15/07/2026
avatar
GMT Eight
TianGe Interactive (01980) announced that the company repurchased 37,000 shares at a cost of HK$21,800 on July 15, 2026, with a repurchase price of HK$0.59 per share.
TIANGE (01980) announced that the company has repurchased 37,000 shares at a cost of 21,800 Hong Kong dollars on July 15, 2026, with a repurchase price of 0.59 Hong Kong dollars per share.
Related Articles
HK Stock
YUM CHINA (09987) spent HKD 7.8521 million to repurchase 22,600 shares on July 14th.
HK Stock
AV CONCEPT HOLD (00595) spent approximately HK$2.2359 million to repurchase 1.67 million shares on July 15th.
HK Stock
Shanghai Fosun Pharmaceutical (02196): FXR0906 injection approved for clinical trials to treat hypertriglyceridemia.
YUM CHINA (09987) spent HKD 7.8521 million to repurchase 22,600 shares on July 14th.
HK Stock
AV CONCEPT HOLD (00595) spent approximately HK$2.2359 million to repurchase 1.67 million shares on July 15th.
HK Stock
Shanghai Fosun Pharmaceutical (02196): FXR0906 injection approved for clinical trials to treat hypertriglyceridemia.
HK Stock
RECOMMEND
Hot A‑Share Stocks Clarify Physical AI, Robotics, Aerospace, and Duty‑Free Themes Amid Frenzied Trading
Hot A‑Share Stocks Clarify Physical AI, Robotics, Aerospace, and Duty‑Free Themes Amid Frenzied Trading
icon
10/06/2026
U.S. AI Trading Frenzy Collapses as Jobs Data Fuels Fed Hike Fears
U.S. AI Trading Frenzy Collapses as Jobs Data Fuels Fed Hike Fears
icon
10/06/2026
Goldman Sachs Warns of AI‑Driven Market Heat, But Bubble Indicators Still Below Historical Extremes
Goldman Sachs Warns of AI‑Driven Market Heat, But Bubble Indicators Still Below Historical Extremes
icon
10/06/2026
logo
Contact US
qr
+852 - 60190728
[email protected]
Customer Support
About Us
Contact Us
Frequently Asked
Privacy Policy
Terms of Use
Commercial Services
Advertising
Business Development
Copyright
Terms of Service
©️2013 - 2026 GMT EIGHT Holdings. All Rights Reserved.